Institutions / Sofinnova Investments, Inc. / Holdings
Back to Sofinnova Investments, Inc.

Sofinnova Investments, Inc.

All holdings · as of Dec 31, 2025

60 positions

CompanyClassValue ↑Shares% of portfolio
ImageneBio, Inc.IMACommon Stock$220.0K31,8840.0%
SOLENO THERAPEUTICS, INC.—$574.8K12,4140.0%
Bolt Biotherapeutics, Inc.BOLTCommon Stock$753.1K137,7210.0%
JADE BIOSCIENCES, INC.—$1.66M107,3910.1%
ACADIA Pharmaceuticals Inc—$1.75M65,5670.1%
Mirum Pharmaceuticals, Inc.—$1.82M23,1000.1%
Savara IncSVRACommon Stock$1.84M304,7700.1%
Ultragenyx Pharmaceutical Inc.—$1.92M83,3000.1%
ESTABLISHMENT LABS HOLDINGS INC.—$2.07M28,3660.1%
Axsome Therapeutics, Inc.—$2.24M12,2660.1%
Evommune, Inc.EVMNCommon Stock$2.62M153,3200.1%
Xenon Pharmaceuticals Inc.—$2.68M59,9000.1%
WAVE LIFE SCIENCES LTD—$2.69M158,1820.1%
NextCure, Inc.NXTCCommon Stock$3.16M222,6540.1%
UNIQURE NV—$4.22M176,5130.2%
Masimo Corporation—$6.01M46,2010.3%
Amylyx Pharmaceuticals, Inc.—$6.37M527,0990.3%
Disc Medicine, Inc.IRONCommon Stock$8.82M111,0100.4%
Exact Sciences Corp.—$10.30M101,4430.4%
Edgewise Therapeutics, Inc.—$10.86M437,8190.5%
GE HealthCare Technologies Inc.—$13.20M160,8760.6%
AnaptysBio, Inc.—$13.95M287,6900.6%
Roivant Sciences Ltd.—$15.94M734,5820.7%
Compass Therapeutics, Inc.—$18.07M3,365,4460.8%
NEKTAR THERAPEUTICS—$18.55M438,6300.8%
Pharvaris N.V.—$20.68M745,1690.9%
Dexcom Inc—$25.10M378,2191.1%
Arcus Biosciences, Inc.—$26.13M1,096,7051.1%
ALCON AG—$26.21M332,5201.1%
INSMED INC—$27.29M156,8011.2%
Supernus Pharmaceuticals Inc—$27.49M553,0951.2%
CENTESSA PHARMACEUTICALS PLC—$27.62M1,104,2741.2%
RHYTHM PHARMACEUTICALS, INC.—$29.05M271,3941.3%
Celcuity Inc.CELCCommon Stock$29.86M299,4171.3%
BioAge Labs, Inc.BIOACommon Stock$30.35M2,293,7881.3%
IDEAYA BIOSCIENCES, INC.—$30.60M885,1211.3%
Glaukos Corp—$32.53M288,1281.4%
ARRIVENT BIOPHARMA INCAVBPCommon Stock$34.14M1,696,7521.5%
Immunome Inc.—$34.76M1,618,4771.5%
Inhibrx Biosciences, Inc.—$35.92M454,6571.5%
IMMATICS N.V—$36.07M3,435,5421.6%
Praxis Precision Medicines, Inc.—$37.06M125,7221.6%
CIDARA THERAPEUTICS INC—$39.82M180,2651.7%
Apogee Therapeutics, Inc.—$40.37M534,8451.7%
BioMarin Pharmaceutical Inc—$41.43M697,1331.8%
Dyne Therapeutics, Inc.—$44.09M2,254,1611.9%
Avidity Biosciences, Inc.—$53.75M745,1162.3%
BridgeBio Pharma, Inc.—$55.11M720,4482.4%
Rapport Therapeutics, Inc.RAPPCommon Stock$57.78M1,904,4082.5%
ELI LILLY & Co—$66.26M61,6522.9%
← PrevPage 1 of 2Next →